HR 2455 · 116th Congress 2019–2021, ended

Ensuring Timely Access to Generics Act of 2019

Latest action · May 2, 2019 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 1, 2019
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Ensuring Timely Access to Generics Act of 2019

This bill requires the Food and Drug Administration (FDA) to consider certain factors in determining whether a petition is submitted for the primary purpose of delaying the approval of a drug application.

The FDA must (1) publish a list of petitions that were submitted with an intent to delay, and (2) establish procedures to refer such petitions to the Federal Trade Commission.

The FDA may establish a timeline for submitting petitions.

Cosponsors 6

Members who signed on, in the order they did. Signatures ran from May 1, 2019 to Jun 13, 2019; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-NYAnthony BrindisiOriginalMay 1, 2019
D-COJason CrowMay 28, 2019
R-FLMichael WaltzMay 28, 2019
R-TXRon WrightMay 28, 2019
R-PABrian K. FitzpatrickJun 5, 2019
R-PALloyd SmuckerJun 13, 2019

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred May 1, 2019
Health Subcommittee
Referred May 2, 2019

Actions 3

Everything that happened, newest first.

  1. May 2, 2019Referred to the Subcommittee on Health.
  2. May 1, 2019Introduced in House
  3. May 1, 2019Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I Section 8 Clause 3--Congress has the ability to regulate Commerce with foreign Nations, and among the several States, and with the Indian Tribes.

The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 71, May 1, 2019, page H3406.

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 1169Ensuring Timely Access to Generics Act of 2019Identical billApr 11, 2019
S 3384Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020Related billMar 3, 2020

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions.
Short Title(s) as Introduced
Ensuring Timely Access to Generics Act of 2019

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 1, 2019Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.